Recent Finacing
Recent Raise
Alpheus Medical develops a non‑invasive sonodynamic drug–device platform combining oral 5‑ALA with low‑intensity diffuse ultrasound to enable outpatient, repeatable, whole‑hemisphere treatment of high‑grade gliomas.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Alpheus Medical.